A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
TME Pharma AG
M.D. Anderson Cancer Center
St. Joseph's Hospital and Medical Center, Phoenix
Northwestern University
University of California, Davis
Betta Pharmaceuticals Co., Ltd.
Children's Oncology Group
Duke University